Immunocore Holdings plc

IMCR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$51-$43-$53-$180
Dep. & Amort.$4$4$5$8
Deferred Tax$0$0-$4-$13
Stock-Based Comp.$34$32$33$49
Change in WC$45$6-$24-$22
Other Non-Cash-$6$4-$7$15
Operating Cash Flow$26$3-$49-$143
Investing Activities
PP&E Inv.-$5-$4-$2-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$350$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$1$0$0
Investing Cash Flow-$355-$5-$2-$1
Financing Activities
Debt Repay.$353$0$0$0
Stock Issued$0$0$140$287
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$9$34$6$1
Financing Cash Flow$344$34$145$288
Forex Effect-$2$8-$13$1
Net Chg. in Cash$13$40$81$144
Supplemental Information
Beg. Cash$443$402$321$177
End Cash$456$443$402$321
Free Cash Flow$21-$2-$51-$144
Immunocore Holdings plc (IMCR) Financial Statements & Key Stats | AlphaPilot